đź“Š Evidence-Based Reference
philips heartstart xl philips heartstart external paddles philips multifunction electrodes
Philips Medical Systems
Summary: The Philips HeartStart XL is a defibrillator designed for emergency cardiac care. It is primarily used in hospital settings for cardiac resuscitation. Key evidence highlights potential issues with message clarity and electromagnetic interference.
FDA Clearance Information
Pathway
510K
Number
K110825 ↗
Decision Date
February 16, 2012
Product Code
MKJ
Device Class
Class 3
Evidence
419 studies
The Philips HeartStart XL was cleared via the FDA 510(k) pathway on February 16, 2012. It is manufactured by Philips Medical Systems and is classified as a Class 3 medical device.
What It Is
The Philips HeartStart XL is a defibrillator intended for use in emergency cardiac care to deliver electrical shocks to the heart in cases of cardiac arrest. It can be used with external paddles or multifunction electrodes to restore normal heart rhythm.
Clinical Applications
This device is commonly used in hospital emergency departments and intensive care units for patients experiencing cardiac arrest. It is crucial in scenarios requiring immediate defibrillation to prevent sudden cardiac death.
Evidence Summary
The literature includes four studies ranging from 2006 to 2013, covering various aspects of the device's performance and safety. Study types include retrospective analyses and case series.
Reported Outcomes
Published studies report that the Philips HeartStart XL is effective in delivering defibrillation therapy. However, issues such as confusing 'No Shock Delivered' messages and potential electromagnetic interference with other devices have been noted.
Safety Profile
Reported complications include confusion due to unclear device messages and potential electromagnetic interference with cardiac resynchronization therapy-pacemakers. These issues could delay therapy or affect device performance.
Evidence Limitations
The evidence is limited by the small number of studies and the lack of large-scale randomized controlled trials. Further research is needed to explore long-term outcomes and to address identified safety concerns.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Philips HeartStart XL?
The device is indicated for use in emergency cardiac care to deliver defibrillation therapy in cases of cardiac arrest.
What outcomes have been reported in clinical studies?
Studies report effective defibrillation but highlight issues with message clarity and electromagnetic interference.
What complications have been reported?
Safety data indicate potential confusion from device messages and interference with other medical devices.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.